When only pathological mutations at an AF of >20% were examined, common mutations were detected in genes encoding TP53, KRAS, and EGFR in adenocarcinoma and in the TP53 gene in squamous cell carcinoma (Figure 2A,B). This evidence concerns the gene EGFR and adenocarcinoma.